Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent  | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Company and Apothecon, Inc. | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2008 | ID-AG | $1,738,719 |
| Celgene Corp. | Bristol-Myers Squibb | pharmaceuticals | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | kickbacks and bribery | 2016 | CA-INS | $30,000,000 |
| Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2011 | CT-ENV | $20,000 |
| E R SQUIBB & SONS LLC | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2013 | NJ-ENV | $5,950 |
| E.R. SQUIBB & SONS | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2009 | NJ-ENV | $10,000 |
| BRISTOL MYERS SQUIBB CO | Bristol-Myers Squibb | pharmaceuticals | hazardous waste violation | 2005 | NJ-ENV | $12,000 |
| BRISTOL-MYERS SQUIBB CO | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2003 | NJ-ENV | $28,000 |
| BRISTOL-MYERS SQUIBB CO | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2001 | NJ-ENV | $6,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2021 | USAO | $75,000,000 |
| Bristol Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2021 | MULTI-AG | $75,000,000 |
| Abraxis Bioscience, Inc. | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2012 | CA-SCAQMD | $5,000 |
| American BioScience Inc. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $815,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $50,000,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,800,000 |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,000,000 |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $19,000,000 |
| BRISTOL-MYERS SQUIBB | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2023 | MA-ENV | $11,615 |
| BRISTOL - MYERS SQUIBB MEDICAL IMAGING INC | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2009 | EPA | $19,538 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2009 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,328,154 |
| Bristol Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2008 | EPA | $66,770 |
| Bristol Myers Squibb Manufacturing Company | Bristol-Myers Squibb | pharmaceuticals | hazardous waste violation | 2008 | EPA | $52,000 |
| E.R. Squibb & Sons LLC | Bristol-Myers Squibb | pharmaceuticals | PCB violation | 2009 | EPA | $8,125 |
| Celgene Corporation | Bristol-Myers Squibb | pharmaceuticals | PCB violation | 2013 | EPA | $6,035 |
| BRISTOL-MYERS SQUIBB COMPANY | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
| CAMBREX CHARLES CITY, INC. | Cambrex | pharmaceuticals | workplace safety or health violation | 2007 | OSHA | $6,375 |
| CAMBREX CHARLES CITY, INC. | Cambrex | pharmaceuticals | workplace safety or health violation | 2018 | OSHA | $18,000 |
| CAMBREX CHARLES CITY, INC | Cambrex | pharmaceuticals | hazardous waste violation | 2006 | EPA | $106,749 |
| Clovis Oncology Inc. | Clovis Oncology | pharmaceuticals | investor protection violation | 2018 | SEC | $20,000,000 |
| CSL Behring, LLC | CSL Limited | pharmaceuticals | air pollution violation | 2021 | EPA | $527,144 |
| CSL Plasma Inc. | CSL Limited | pharmaceuticals | privacy violation | 2022 | private lawsuit-federal | $9,900,000 |
| CSL Limited | CSL Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2014 | private lawsuit-federal | $64,000,000 |
| ZLB Behring, L.L.C. | CSL Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| CSL PLASMA | CSL Limited | pharmaceuticals | workplace safety or health violation | 2019 | OSHA | $15,422 |
| CSL Behring LLC | CSL Limited | pharmaceuticals | air pollution violation | 2015 | EPA | $62,780 |
| CSL BEHRING LLC | CSL Limited | pharmaceuticals | air pollution violation | 2021 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $527,144 |
| AMRI Rensselaer, Inc. | Curia Inc. | pharmaceuticals | environmental violation | 2018 | NY-ENV | $21,250 |
| AMRI Rensselaer, Inc. | Curia Inc. | pharmaceuticals | environmental violation | 2014 | NY-ENV | $45,000 |
| Cypress Pharmaceutical Inc. | Currax Pharmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $2,800,000 |
| PERNIX THERAPEUTICS, LLC | Currax Pharmaceuticals | pharmaceuticals | benefit plan administrator violation | 2019 | EBSA | $10,001 |
| Pernix Therapeutics | Currax Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $800,000 |
| Pernix Therapeutics, LLC | Currax Pharmaceuticals | pharmaceuticals | WARN Act violation | 2019 | private lawsuit-federal | $300,000 |
| Cytrx Corporation | CytRx | pharmaceuticals | investor protection violation | 2017 | SEC | $75,000 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $4,340,100 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $1,446,700 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
| Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories | pharmaceuticals | drug or medical equipment safety violation | 2018 | DOJ_CIVIL | $5,000,000 |
| Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | pharmaceuticals | False Claims Act and related | 2022 | TX-AG | $12,900,000 |
| Dr. Reddy's Laboratories Ltd. | Dr. Reddy's Laboratories | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $400,000 |
| Eisai Inc. | Eisai | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $11,000,000 |
| Eisai | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $7,634,700 |
| Eisai | Eisai | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,000,000 |
| Eisai Co. | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $2,544,900 |
| Eisai Co. | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
| Eisai Company | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
| EISAI INC. | Eisai | pharmaceuticals | workplace safety or health violation | 2010 | OSHA | $6,376 |
| ELANCO ANIMAL HEALTH A DIV OF ELI LILLY & CO CLINTON LABS | Elanco Animal Health | pharmaceuticals | air pollution violation | 2013 | IN-ENV | $20,000 |
| ELANCO ANIMAL HEALTH A DIV OF ELI LILLY & CO CLINTON LABS | Elanco Animal Health | pharmaceuticals | air pollution violation | 2002 | IN-ENV | $17,000 |
| Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | pharmaceuticals | hazardous waste violation | 2012 | EPA | $68,475 |
| Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | pharmaceuticals | air pollution violation | 2011 | EPA | $300,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | FDA | $36,000,000 |
| Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | AR-AG | $18,500,000 |
| Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MS-AG | $18,500,000 |
| Eli Lilly | Eli Lilly | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,650,000 |
| Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | LA-AG | $20,000,000 |
| Eli Lilly & Co. | Eli Lilly | pharmaceuticals | privacy violation | 2002 | MULTI-AG | $160,000 |
| Eli Lilly and Co. | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | CT-AG | $25,100,000 |
| Eli Lilly and Co. | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | ID-AG | $13,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | $62,000,000 |
| ELI LILLY & CO LTC | Eli Lilly | pharmaceuticals | air pollution violation | 2019 | IN-ENV | $45,000 |
| LILLY DEL CARIBE INC | Eli Lilly | pharmaceuticals | environmental violation | 2000 | EPA | $39,000 |
| LILLY DEL CARIBE, INC. | Eli Lilly | pharmaceuticals | water pollution violation | 2000 | EPA | $90,000 |
| Lilly Del Caribe, Inc. | Eli Lilly | pharmaceuticals | hazardous waste violation | 2003 | EPA | $68,992 |
| Novartis Animal Health US, Inc. | Eli Lilly | pharmaceuticals | environmental violation | 2006 | EPA | $6,500 |
| ELI LILLY AND COMPANY | Eli Lilly | pharmaceuticals | air pollution violation | 2011 | EPA | $337,500 |
| ELI LILLY & COMPANY - TIPPECANOE LABS | Eli Lilly | pharmaceuticals | air pollution violation | 2009 | EPA | $12,000 |
| BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | pharmaceuticals | air pollution violation | 2011 | EPA | $900,000 |
| BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | pharmaceuticals | hazardous waste violation | 2012 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $338,475 |
| Endo Health Solutions Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | FDA | $192,700,000 |
| Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $45,000,000 |
| Dava Pharmaceuticals Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2012 | DOJ_CIVIL | $11,000,000 |
| Dava Pharmaceuticals, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $11,000,000 |
| Endo Health Solution | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000 |
| Endo Health Solutions | Endo International | pharmaceuticals | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $39,000,000 |
| Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | Endo International | pharmaceuticals | drug or medical equipment safety violation | 2016 | NY-AG | $200,000 |
| Endo International plc | Endo International | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | MULTI-AG | $2,300,000 |
| Endo Pharmaceuticals | Endo International | pharmaceuticals | consumer protection violation | 2019 | CA-AG | $760,000 |
| Endo Pharmaceuticals | Endo International | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
| Par Pharmaceutical | Endo International | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $6,000,000 |
| Par Pharmaceutical Co. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
| Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,500,000 |
| Par Pharmaceutical Cos., Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $1,700,000 |
| Par Pharmaceutical Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | KY-AG | $4,500,000 |
| Par Pharmaceutical, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $500,000 |
| Par Pharmaceuticals, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | MULTI-AG | $154,000,000 |
| Endo Health Solutions Inc. | Endo International | pharmaceuticals | product safety violation | 2017 | private lawsuit-federal | $15,500,000 |
| IMMUNOMEDICS, INC. EMPLOYEES' 401(K) SAVINGS PLAN | Gilead Sciences | pharmaceuticals | benefit plan administrator violation | 2001 | EBSA | $10,001 |
| Gilead Sciences | Gilead Sciences | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $250,000 |
